Live from AUA: Dr. Bevan-Thomas Explains The Latest Prostate Cancer News

What are some new developments that prostate cancer patients should know about?

PCLHOAfeatAt Prostate Cancer Live, we are dedicated to keeping prostate cancer patients and their loved ones updated on all the latest news and developments in the medical world. It is with this mission in mind that we reported live with our medical director Dr. Bevan Thomas from the American Urological Assocation’s 2014 Annual Meeting.

In this short Hangout on Air, which you can view below on-demand, Dr. Bevan-Thomas discussed the latest prostate cancer news from AUA 2014:

Personalized treatment options and the Oncotype DX test

Fusion biopsy and other advances in technology

Effects of nutrition and exercise on prostate cancer patients undergoing ADT (androgen deprivation therapy)

Full Hangout:

Dr. Richard Bevan-Thomas
Dr. Bevan-Thomas is the Medical Director for Prostate Cancer Live. A graduate of Duke University, Rich received both a master’s degree in anatomy and his medical degree from St. Louis University School of Medicine. He completed residency training in urologic surgery at the University of Texas Houston Health Science Center and the renowned MD Anderson Cancer Center, also in Houston. In 2002, he received two top honors in his field; the Pfizer Scholar in Urology and the Gerald G. Murphy Scholar in Urology. Dr. Bevan-Thomas will remain on the leading edge of robotic surgery and cryosurgery at USMD Prostate Cancer Center and will continue offering patients the latest clinical trials in prostate cancer treatment. He continues his teaching and physician proctoring interests as well as instructing in robotic surgery.

This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.

© 2016 Cancer Answers LLC